ERBB Receptors and Cancer: the Complexity of Targeted Inhibitors.

Nature Rev. Cancer 5, 341–354 (2005) The authors would like to correct Figure 4b of this article. The statement in the figure legend that reads “The epidermal growth factor receptor variant III (EGFRvarIII) cannot bind cetuximab or matuzumab” is incorrect. Wu and colleagues1 have shown that cetuximab does bind EGFRvarIII.